US FDA approves Astellas drug for leaky bladder

WASHINGTON, June 28 Thu Jun 28, 2012 1:52pm EDT

WASHINGTON, June 28 (Reuters) - U.S. drugs regulators gave the nod to Astellas Pharma Inc's pill for overactive bladder on Thursday, boosting the Japanese drugmaker's foothold in the market for the condition.

The Food and Drug Administration approved the once-daily pill, mirabegron, for adults who cannot control their bladder muscles, following a positive recommendation from FDA advisers.


After wave of QE, onus shifts to leaders to boost economy

DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.